Scorecard
| Current Price | Fair | |
| Yield (%) – Higher is better Current Yield: 4.28% Industry Average: 2.74% | ||
| Dividend Growth (%) – Higher is better Dividend Growth: 3.33% Industry Average: 6.42% | ||
| Returns (%) – Higher is better Returns: 27.68% Industry Average: 23.51% | ||
| Free Cash Flow Payout Ratio (%) – Lower is better FCFPR: 40.08% Industry Average: 51.70% | ||
BRISTOL-MYERS SQUIBB COMPANY
(XNYS:BMY)
Industry: Pharmaceuticals
| Price | Change (Daily) |
| $ 58.82 | $ -0.93 |
Dividend
Annual Dividend | Annual Yield |
$ 2.52 | 4.28 % |
Dividend Streak | 5 Year Average |
17 year(s) | 3.93 % |
Fair Price
Current Stock price is considered: Fair
| Current Price ● $ 58.82 |
| Less Than $51.99 | $51.99 – $82.13 | More Than $82.13 |
| Undervalued | Fair Price | Overvalued |
Using average Dividend Yield for stock valuation. Learn about this method for Fair Price analysis HERE.
Growth
Dividend Growth Rate
1 Year | 3 Year | 5 Year |
3.33 % | 4.72 % | 6.65 % |
| 2021 | 2022 | 2023 | 2024 | 2025 |
| $ 1.96 | $ 2.16 | $ 2.28 | $ 2.40 | $ 2.48 |
Price Return
1 Year | 5 Year | CAGR 5 Years |
$ 12.75 27.68 % | $ 0.42 | 0.14 % |
